Glucosyltransferase immunogens

Details Glucosyltransferase immunogens Glucosyltransferase immunogens

2006-06-06

2006-06-06

Swartz, Rodney P (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S009100, C424S009200, C424S184100, C424S185100, C424S193100, C424S197110, C424S234100, C424S244100, C435S069100, C435S183000, C435S193000, C435S253400, C530S300000, C530S350000

Reexamination Certificate

active

07056517

ABSTRACT:
Vaccine compositions and immunogenic compositions are described which are glucosyltransferase subunit vaccines for dental caries and which contain at least one peptide which corresponds to a sequence of glucosyltransferase containing aspartate 413, an equivalent of aspartate 413, aspartate 451, an equivalent of aspartate 451, aspartate 562, an equivalent of aspartate 562, aspartate 567, an equivalent of aspartate 567, histidine 561, an equivalent of histidine 561, tryptophan 491, an equivalent of tryptophan 491, glutamate 489, an equivalent of glutamate 489, arginine 449, an equivalent of arginine 449, or combinations thereof. These subunit vaccines elicit antibodies which protect an immunized mammal from dental caries. Methods of provoking an immune response to intact glucosyltransferase are also described.

REFERENCES:
patent: 4150116 (1979-04-01), Taubman et al.
patent: 4250262 (1981-02-01), Taubman et al.
patent: 4438200 (1984-03-01), Taubman et al.
patent: 5019400 (1991-05-01), Gombotz et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5686075 (1997-11-01), Taubman et al.
patent: WO 90/02809 (1990-03-01), None
patent: WO 91/17271 (1991-11-01), None
patent: WO 92/01047 (1992-01-01), None
patent: WO 92/09690 (1992-06-01), None
patent: WO 92/15679 (1992-09-01), None
patent: WO 92/18619 (1992-10-01), None
patent: WO 92/20791 (1992-11-01), None
patent: WO 93/01288 (1993-01-01), None
patent: WO 99/07828 (1999-02-01), None
Banas, et al.,Infect. Immun., 58(3):667-673 (1990).
Banas, et al.,FEMS Microbiol. Lett., 154:289-292 (1997).
Chia, et al.,Infect. Immun., 61(11):4689-4695 (1993).
Chia, et al.,Infect. Immun., 69(4):2493-2501 (2001).
Cole, et al.,Monoclonal Antibodies and Cancer Therapy, pp. 77-96 (1985).
Dertzbaugh, et al.,Infect. Immun., 58(6):1509-1513 (1990).
Dertzbaugh, et al.,Infect. Immun., 58(1):70-79 (1990).
Devulapalle, et al.,Protein Sci., 6:2489-2493 (1997).
Ferretti, et al.,J. Bacteriol., 169(9):4271-4278 (1987).
Ferretti, et al.,Infect. Immun., 56(6):1585-1588 (1988).
Fuchs, et al.,Biotechnology, 9:1369-1372 (1991).
Funane, et al.,Biochem., 32:13696-13702 (1993).
Furst, et al.,Nucleic Acids Res., 17(16):6274 (1989).
Galfre, et al.,Nature, 266(5602):550-552 (1977).
GenBank Accession No. AY046410 (2001).
GenBank Accession No. AY046411 (2001).
GenBank Accession No. AY046412 (2001).
GenBank Accession No. AY046413 (2001).
GenBank Accession No. AY046414 (2001).
Griffiths, et al.,EMBO J., 12(2):725-734 (1993).
Hamada, et al.,Microbiol. Rev., 44(2):331-384 (1980).
Hay, et al.,Hum. Antibod. Hybridomas, 3:81-85 (1992).
Higgins, et al.,CABIOS Communications, 5(2):151-153 (1989).
Hopp, et al.,Proc. Natl. Acad. Sci. USA, 78(6):3824-3828 (1981).
Huse, et al.,Science, 246:1275-1281 (1989).
Jenkins, et al.,FEBS Lett., 362:281-285 (1995).
Jespergaard, et al.,Infect. Immun., 67(2):810-816 (1999).
Jespergaard, et al.,Infect. Immun., 67(12):6543-6549 (1999).
Keyes, et al.,Arch. Oral Biol., 9:377-400 (1964).
Köhler, et al.,Nature, 266(5602):495-497 (1975).
Kolenbrander, P.E.,Annu. Rev. Microbiol., 54:413-437 (2000).
Kuramitsu, et al.,Archs. Oral Biol., 23(8):691-696 (1978).
Lerner, E.A.,Yale J. Biol. Med., 54(5):387-402 (1981).
Loo, et al.,J. Bacteriol., 182(5):1374-1382 (2000).
Ma, et al.,Eur. J. Immunol., 24:131-138 (1994).
MacGregor, et al.,FEBS Lett., 378:263-266 (1996).
Matsuura, et al.,J. Biochem., 95:697-702 (1984).
Mattos-Graner, et al.,J. Dent. Res., 79(6):1371-1377 (2000).
Mattos-Graner, et al.,Infect. Immun., 69(11):6931-6941 (2001).
Merrifield, R.B.,Synthesis of a Tetrapeptide, 85:2149-2154 (1963).
Mooser, et al.,J. Dental Res., Abstract 1729, 69:325 (1990).
Mooser, et al.,J. Biol. Chem., 266(14):8916-8922 (1991).
Navarre, et al.,Mol. Microbiol., 14(1):115-121 (1994).
Reinscheid, et al.,J. Bacteriol., 183(40:1175-1183 (2001).
Russell, R.R.B.,J. Gen. Microbiol., 112:197-201 (1979).
Russell, et al.,J. Dental Res., 67(3):543-547 (1988).
Sato, et al.,Infect. Immun., 65(2):668-675 (1997).
Schubert, et al.,Arch. Microbiol., 173(1):21-28 (2000).
Shimamura, et al.,J. Bacteriol., 176(16):4845-4850 (1994).
Shiroza, et al.,J. Bacteriol., 169:4263-4270 (1987).
Smith, et al.,Infect. Immun., 21(3):843-851 (1978).
Smith, et al.,Infect. Immun., 23(2):446-452 (1979).
Smith, et al.,Infect. Immun., 26(1):82-89 (1979).
Smith, et al.,Infect. Immun., 28(2):441-450 (1980).
Smith, et al.,Archs. Oral Biol., 26:871-878 (1981).
Smith, et al.,Infect. Immun., 37(2):656-661(1982).
Smith, et al.,Infect. Immun., 42(1):156-162 (1983).
Smith, et al.,Infect. Immun., 55(11):2562-2569 (1987).
Smith, et al.,Oral Microbiol. Immun., 5(2):57-62 (1990).
Smith, et al.,J. Clin. Immunol., 10(5):273-281 (1990).
Smith, et al.,Infect. Immun., 61(7):2899-2905 (1993).
Smith, et al.,Oral Microbiol. Immun., 13(5):278-285 (1998).
Smith, et al.,Infect. Immun., 62(6):2545-2552 (1994).
Smith, et al.,Infect. Immun., 62(12):5470-5476 (1994).
Smith, et al.,Oral Micro Immunol., 9:65-69 (1994).
Smith, et al.,J. Dental Res., Abstract 818, 77:734 (1998).
Smith, et al.,Infect. Immun., 67(5):2638-2642 (1999).
Smith, et al.,J. Dental Res., 78:422 (1999).
Smith, et al.,Oral Microbiol. Immunol., 15:124-130 (2000).
Smith, et al.,Infect. Immun., 69(5):3135-3142 (2001).
Smith, et al.,Infect. Immun., 69(8):4767-4773 (2001).
Smith, et al.,Infect. Immun., 64(8):3069-3073 (1996).
Smith, et al.,Infect. Immun., 65(11):4424-4430 (1997).
Socransky, et al.,J. Clin. Microbiol., 22(2):303-305 (1985).
Søgaard, et al.,J. Biol. Chem., 268(30):22480-22484 (1993).
Svendsen, et al.,Lab. Anim. Sci., 45(1):89-93 (1995).
Tam, J.P.,Proc. Natl. Acad. Sci. USA, 85(15):5409-5413 (1988).
Taubman, et al.,J. Immunol., 118(2):710-720 (1977).
Taubman, et al.,Recent Advances in Mucosal Immunity, W. Strober, et al., eds. (NY Raven Press) pp. 371-382 (1982).
Taubman, et al.,Glucosyltransferase, Glucans, Sucrose and Dental Caries, Doyle, et al., eds., Sp. Supp.,Chemical Senses, pp. 249-258 (1983).
Taubman, et al.,J. Oral Pathol., 17:466-470 (1988).
Taubman, et al.,Infect. Immun., 63(8):3088-3093 (1995).
Taubman, et al.,J. Dent. Res., Abstract 2666, 76:347 (1997).
Taubman, et al.,Infect. Immun., 68(5):2698-2703 (2000).
Taubman, et al.,Infect. Immun., 69:4210-4216 (2001).
Tsumori, et al.,J. Bacteriol., 179(11):3391-3396 (1997).
Ueda, et al.,Gene, 69:101-109 (1988).
U.S. non-published pending Appl. No. 09/562,328 by Andrew Lees, Martin A. Taubman and Daniel J. Smith, filed May 1, 2000.
U.S. Appl. No. 08/967,573 by Daniel J. Smith and Martin A. Taubman, filed Nov. 10, 1997.
Van Houte, et l.,J. Dent. Res., 68(3):451-459 (1989).

Affiliated with

Also associated with

Rating

Glucosyltransferase immunogens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucosyltransferase immunogens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucosyltransferase immunogens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3654215